News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilent Technologies Inc. (A) And SISCAPA Assay Technologies Provide Complete Solution For Targeted Multiplexed Protein Quantitation To Enhance Customer Workflows


5/27/2014 10:54:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif. & WASHINGTON--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and SISCAPA Assay Technologies (SAT) today announced they have signed a non-exclusive agreement to enable SAT to provide an end-to-end solution for multiplexed protein quantitation using a highly automated workflow for SISCAPA LC-mass spectrometry. This solution will combine SAT’s reagents for targeted protein quantitation with Agilent’s Bravo Automated Liquid Handling Platform for sample preparation, along with liquid chromatography–mass spectrometers (LC/MS) for quantitative analysis. The agreement expands on an established strategic relationship between Agilent and SAT, furthering both companies’ ability to enhance customer workflows.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES